Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment

Throughout the United States, cancer remains the second leading cause of death. Traditional treatments induce significant medical toxic effects and unpleasant adverse reactions, making them inappropriate for long-term use. Consequently, anticancer-drug resistance and relapse are frequent in certain...

Descrición completa

Detalles Bibliográficos

Principais autores:	Salar Hafez Ghoran, Andrea Calcaterra, Milad Abbasi, Fatemeh Taktaz, Kay Nieselt, Esmaeil Babaei
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-08-01
Series:	Molecules
Assuntos:	nanocurcumin cancer treatment nanocarriers drug delivery system curcumin nanoformulations cancer immunotherapy
Acceso en liña:	https://www.mdpi.com/1420-3049/27/16/5236
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!